GMTX
Gemini Therapeutics Inc
Price:  
1.35 
USD
Volume:  
63,882.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GMTX WACC - Weighted Average Cost of Capital

The WACC of Gemini Therapeutics Inc (GMTX) is 6.5%.

The Cost of Equity of Gemini Therapeutics Inc (GMTX) is 9.35%.
The Cost of Debt of Gemini Therapeutics Inc (GMTX) is 5.00%.

Range Selected
Cost of equity 8.30% - 10.40% 9.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.0% - 7.0% 6.5%
WACC

GMTX WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.82 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 10.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.0% 7.0%
Selected WACC 6.5%